Therapeutic agents

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/137 (2006.01) A61K 31/40 (2006.01) A61K 31/495 (2006.01) A61K 31/505 (2006.01) A61K 45/06 (2006.01) A61P 3/04 (2006.01)

Patent

CA 2400797

The present invention provides a method of treating and preventing obesity and related co-morbid conditions comprising the administration of a therapeutically effective amount of one or more monoamine reuptake inhibitors which are serotonin reuptake inhibitors and/or noradrenaline reuptake inhibitors and a 5-HT1A agonist to a patient in need thereof.

La présente invention concerne un procédé permettant de traiter et de prévenir l'obésité et les conditions de cobormidité associées, qui consiste à administrer une quantité thérapeutiquement efficace d'un ou plusieurs inhibiteurs du recaptage de la monoamine qui sont des inhibiteurs du recaptage de la sérotonine et/ou de la noradrénaline et un agoniste de 5-HT¿1A? à un patient qui en a besoin.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2005800

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.